A resolution expressing support for the designation of September 2022 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

Bill 117 sres 868 is a resolution that aims to designate September 2022 as "Sickle Cell Disease Awareness Month" in the United States. The purpose of this designation is to educate communities about sickle cell disease and the importance of research, early detection methods, effective treatments, and preventative care programs for individuals affected by the disease.

Sickle cell disease is a genetic blood disorder that affects red blood cells, causing them to become rigid and sickle-shaped. This can lead to various complications, including pain, organ damage, and an increased risk of infections. It is particularly prevalent among African Americans and Hispanic Americans, although it can affect people of any race or ethnicity.

The resolution emphasizes the need for increased awareness and understanding of sickle cell disease in order to improve outcomes for individuals living with the condition. By designating September 2022 as "Sickle Cell Disease Awareness Month," the hope is to raise awareness about the disease and promote the importance of early detection, effective treatments, and preventative care programs. Overall, Bill 117 sres 868 seeks to highlight the challenges faced by individuals with sickle cell disease and to encourage efforts to improve the quality of life for those affected by the condition. By promoting education and awareness, the resolution aims to support research and initiatives that can lead to better outcomes for individuals living with sickle cell disease and related conditions.